- BioTech News
Biotechnology, Human Enhancement, and the Ends of Medicine
by Edmund D. Pellegrino
by Edmund D. Pellegrino
The actual and promised capabilities of biotechnology have given prominence to a possible new end of medicine: "enhancement." Almost every present-day commentator underscores the difficulties, impossibility, or futility of any definition that seeks to distinguish enhancement from therapy [1]. Nonetheless, everyone eventually ends up using the term since no viable substitute has yet appeared. In short, no boundary between morally valid and invalid uses of biotechnology can be established without at least a working definition.
In this essay, my operating definition of enhancement will be grounded in its general etymological meaning — i.e., to increase, intensify, raise up, exalt, heighten, or magnify. Each of these terms carries the connotation of going "beyond" what exists at some moment, whether it is a certain state of affairs, a bodily function or trait, or a general limitation built into human nature. Enhancement is, as Fowler says, "A dangerous word for the unwary," but its use in some form seems inescapable [2]. For this discussion, enhancement will signify an intervention that goes beyond the ends of medicine as they traditionally have been held.
For medicine, the treatment/enhancement distinction cannot be avoided since physicians will play a central role whenever medical knowledge is used, both to regain health and to go beyond what is required to regain health. To be sure, specialists in other fields are necessary if even the modest promises of biotechnology are to be realized. They will provide the basic scientific and technical expertise from which biotechnological enhancements will emerge. But physicians are crucial in the actual use of this technology with individual human beings.
Some physicians have already crossed the divide between treatment and enhancement, between medically indicated use and patient-desired abuse. There is already a need for physicians to reflect on the ethical implications of their involvement in the uses of biotechnology. This reflection centers on these loci: (1) The use of biotechnological advancements in the treatment of disease; (2) its use to satisfy the desires of patients and non-patients for enhancement of some bodily or mental trait, or some state of affairs they wish to perfect; and (3) more distantly, in the use of biotechnology to redesign human nature and thus to enhance the species in the future.
New treatments are the most promising use of biotechnology. They most closely conform to the clinical and ethical ends of medicine. The list of target diseases is long. Devising treatments for them is a legitimate and desirable individual and social good. Here, the physician functions in his time-honored role as healer. He has a moral obligation to stay informed and educated in the use of the new technologies.
The ethical questions are related to the means by which these new treatments are developed and applied. Genetic manipulations, cybernetics, nanotechnology, and psychopharmacology are in themselves not intrinsically good nor bad morally. Procedures, however, derived from the destruction of human embryos, distortions and bypassing of normal reproductive processes, or cloning of human beings, etc., are not morally permissible no matter how useful they might be therapeutically.
Within the traditional ends of medicine, the primary intention is the use of biotechnology to treat physical or mental disease. There is no question that the cure or amelioration of a disease process will also result secondarily in enhancement of the patient's life. Here the enhancement lies in the restoration of health or relief of symptoms undermined by disease. The patient feels "better" and regains functional capacity. He may be returned to his previous state of health, or to an even better state. This kind of enhancement follows therapy and is part of the aim of therapy — it is not "beyond" therapy, but a result of it. This is different from enhancement as a primary intention. Here we start with someone who has no disease or obvious bodily malformation. She is considered "normal" in the usual sense of that term. Yet the person feels dissatisfied with her portion in life. She feels unfulfilled, at a social disadvantage, or competitively deficient in some mental or physical bodily trait. She may want to augment a state to what she thinks is a normal level, or she may want something approaching perfection.
The motives, ends, and means of enhancement as a primary intention are morally variable. Some ends — like the desire for healthy, bright, and lovable children — are understandable. If the means that bring these states about do not themselves dehumanize their subjects, they might be within the legitimate ends of medicine, particularly preventative medicine.
On the other hand, many others will focus elsewhere — e.g., on the thrills of going farther, faster, with more endurance in athletic competition. Alternatively, they might want to enjoy the adrenaline surge of seeing how far the human body and mind can be pushed. Enhancement of this kind becomes an end in itself far beyond the healing ends of medicine in any traditional sense.
Some would extend the term "patient" to anyone unhappy, in any degree, with his body, mind, soul, or psyche. This would "medicalize" every facet of human existence. Were physicians to accept enhancement of this kind as their domain, the social consequences would be dire. The number of physicians needed would skyrocket; access for those with disease states would be compromised; research and development would become even more commercialized and industrialized. Research resources would be channeled away from therapy per se. The gap in access to therapy between those able to pay for the doctor's time and those who cannot would expand. To make physicians into enhancement therapists is to make therapy a happiness nostrum, not a true healing enterprise.
On the other hand, if any significant number of physicians were to decide that enhancement, as an end in itself, is not the physician's responsibility, enhancement therapy could become a field of its own "beyond" medicine. How these new therapists would relate to patients and physicians is unclear. Would they be simply those physicians willing to cooperate? Would they be persons in other fields — like sports trainers, psychologists, naturopaths, who would attend to their own special spectrum of enhancement requests? What would these enhancement therapists do when serious, mysterious, or potentially lethal side effects appeared?
It is likely that outright rejection of enhancement would encounter strong resistance. Satisfaction of personal desires, freedom of choice, and "quality of life" have, for many, become entitlements in a democratic society. Few will want restrictions placed on their choice of enhancement. Peer pressure, the drive of a competitive society, and market pressures will convince many physicians and ethicists that resistance is futile.
Given our society's incessant search for satisfaction of all its desires in this world, many will argue that enhancement is part of the physician's responsibilities — no matter what the profession thinks. The confluence of an ego-oriented culture sustained by social approval, peer example, and clever advertising will produce a cascade of demand.
Physicians will be drawn into enhancement practices for a variety of reasons. Some will see only good in it; some will accept it as "treatment" for the unhappiness and depression suffered by those who are not everything they want to be. Others will argue that physician involvement is necessary to assure safety and to permit better regulation of abuses. "What better way to treat the whole person?" some may add. "Isn't the patient the one who knows most about his own good?" Assertions like these suggest that failure to provide enhancement may become a breach of the physician-patient relationship or the physician's social contract.
Enhancement will also appeal to the physician's self-interest. A willing and paying clientele is certain to develop. Patients will be more eager to pay for the enhancement of the lifestyles they desire than for treatment of diseases they did not want in the first place. Physicians can say they are doing "good" for their patients even while doing well for themselves.
The possibility and probability of a serious conflict of interests on the part of the physician cannot be ignored. Money can easily induce the physician to provide enhancement of dubious merit or marginal efficacy. More specific, for example, is the conflict that involves the team physician who is expected to do his part to produce a winning team. Enhancements of athletic performance are in worldwide use. Their deleterious side effects are well known. Who does the physician serve — the good of the patient, the success of the team that pays his salary, or his own infatuation with athletic success?
Fundamental questions about how enhancement affects our concepts of the purposes of human life and the nature of human happiness will be buried by more immediate demands for happiness, fulfillment, and mental tranquility [3]. The modern and post-modern emphasis will be on effective regulatory measures, better techniques, and competent practitioners — not ethical restraint. Restraint or prohibition beyond prevention of abuses and harmful side effects is highly unlikely. Those who restrict freedom of choice will be seen as a danger to the realization of a higher quality of life for all. Any restriction will be interpreted as a violation of the physician's obligation to respect patient autonomy.
Many of us will take these to be specious arguments, which, if accepted, would make medicine the handmaiden of biotechnology and erode its traditional role in treating the sick. Counterarguments will be difficult given the powerful vectors of change in our cultural mores. Hopes for an earthly paradise are seemingly within reach for many people who no longer believe in an after-life. For them, extracting the maximum from personal enhancement is a seductive substitute.
About the Author
Edmund D. Pellegrino, M.D., is Professor Emeritus of Medicine and Medical Ethics at the Center for Clinical Medical Ethics at Georgetown University Medical Center. He was the John Carroll Professor of Medicine and Medical Ethics and the former director of the Kennedy Institute of Ethics, the Center for the Advanced Study of Ethics at Georgetown University, and the Center for Clinical Bioethics. Dr. Pellegrino is a Senior Fellow of The Center for Bioethics and Human Dignity.
References
1 Parens, E. 1998. "Is better always good?" In: E., Parens (Ed.), Enhancing human traits: Ethical and social implications (pp. 1-28). Washington, DC: Georgetown University Press; Jeungst, E. 1998. "What does enhancement mean?" In: E., Parens (Ed.), Enhancing human traits: Ethical and social implications (pp. 29-69). Washington, DC: Georgetown University Press.
2 Fowler, H. J. 1965. A dictionary of English usage. 2nd Edition. Revised by Sir Ernest Gowers. New York, NY: Oxford University Press.
3 Krammer, P. 1993. Listening to Prozac. New York: Viking.
On the net:
The Center for Bioethics and Human Dignity
www.cbhd.org
www.cbhd.org/resources/biotech/pellegrino_2004-11-30.htm
|
 |
| + Enlarge | |
|
''Within the traditional ends of medicine, the primary intention is the use of biotechnology to treat physical or mental disease.'' |
For medicine, the treatment/enhancement distinction cannot be avoided since physicians will play a central role whenever medical knowledge is used, both to regain health and to go beyond what is required to regain health. To be sure, specialists in other fields are necessary if even the modest promises of biotechnology are to be realized. They will provide the basic scientific and technical expertise from which biotechnological enhancements will emerge. But physicians are crucial in the actual use of this technology with individual human beings.
Some physicians have already crossed the divide between treatment and enhancement, between medically indicated use and patient-desired abuse. There is already a need for physicians to reflect on the ethical implications of their involvement in the uses of biotechnology. This reflection centers on these loci: (1) The use of biotechnological advancements in the treatment of disease; (2) its use to satisfy the desires of patients and non-patients for enhancement of some bodily or mental trait, or some state of affairs they wish to perfect; and (3) more distantly, in the use of biotechnology to redesign human nature and thus to enhance the species in the future.
New treatments are the most promising use of biotechnology. They most closely conform to the clinical and ethical ends of medicine. The list of target diseases is long. Devising treatments for them is a legitimate and desirable individual and social good. Here, the physician functions in his time-honored role as healer. He has a moral obligation to stay informed and educated in the use of the new technologies.
The ethical questions are related to the means by which these new treatments are developed and applied. Genetic manipulations, cybernetics, nanotechnology, and psychopharmacology are in themselves not intrinsically good nor bad morally. Procedures, however, derived from the destruction of human embryos, distortions and bypassing of normal reproductive processes, or cloning of human beings, etc., are not morally permissible no matter how useful they might be therapeutically.
Within the traditional ends of medicine, the primary intention is the use of biotechnology to treat physical or mental disease. There is no question that the cure or amelioration of a disease process will also result secondarily in enhancement of the patient's life. Here the enhancement lies in the restoration of health or relief of symptoms undermined by disease. The patient feels "better" and regains functional capacity. He may be returned to his previous state of health, or to an even better state. This kind of enhancement follows therapy and is part of the aim of therapy — it is not "beyond" therapy, but a result of it. This is different from enhancement as a primary intention. Here we start with someone who has no disease or obvious bodily malformation. She is considered "normal" in the usual sense of that term. Yet the person feels dissatisfied with her portion in life. She feels unfulfilled, at a social disadvantage, or competitively deficient in some mental or physical bodily trait. She may want to augment a state to what she thinks is a normal level, or she may want something approaching perfection.
The motives, ends, and means of enhancement as a primary intention are morally variable. Some ends — like the desire for healthy, bright, and lovable children — are understandable. If the means that bring these states about do not themselves dehumanize their subjects, they might be within the legitimate ends of medicine, particularly preventative medicine.
On the other hand, many others will focus elsewhere — e.g., on the thrills of going farther, faster, with more endurance in athletic competition. Alternatively, they might want to enjoy the adrenaline surge of seeing how far the human body and mind can be pushed. Enhancement of this kind becomes an end in itself far beyond the healing ends of medicine in any traditional sense.
Some would extend the term "patient" to anyone unhappy, in any degree, with his body, mind, soul, or psyche. This would "medicalize" every facet of human existence. Were physicians to accept enhancement of this kind as their domain, the social consequences would be dire. The number of physicians needed would skyrocket; access for those with disease states would be compromised; research and development would become even more commercialized and industrialized. Research resources would be channeled away from therapy per se. The gap in access to therapy between those able to pay for the doctor's time and those who cannot would expand. To make physicians into enhancement therapists is to make therapy a happiness nostrum, not a true healing enterprise.
On the other hand, if any significant number of physicians were to decide that enhancement, as an end in itself, is not the physician's responsibility, enhancement therapy could become a field of its own "beyond" medicine. How these new therapists would relate to patients and physicians is unclear. Would they be simply those physicians willing to cooperate? Would they be persons in other fields — like sports trainers, psychologists, naturopaths, who would attend to their own special spectrum of enhancement requests? What would these enhancement therapists do when serious, mysterious, or potentially lethal side effects appeared?
It is likely that outright rejection of enhancement would encounter strong resistance. Satisfaction of personal desires, freedom of choice, and "quality of life" have, for many, become entitlements in a democratic society. Few will want restrictions placed on their choice of enhancement. Peer pressure, the drive of a competitive society, and market pressures will convince many physicians and ethicists that resistance is futile.
Given our society's incessant search for satisfaction of all its desires in this world, many will argue that enhancement is part of the physician's responsibilities — no matter what the profession thinks. The confluence of an ego-oriented culture sustained by social approval, peer example, and clever advertising will produce a cascade of demand.
Physicians will be drawn into enhancement practices for a variety of reasons. Some will see only good in it; some will accept it as "treatment" for the unhappiness and depression suffered by those who are not everything they want to be. Others will argue that physician involvement is necessary to assure safety and to permit better regulation of abuses. "What better way to treat the whole person?" some may add. "Isn't the patient the one who knows most about his own good?" Assertions like these suggest that failure to provide enhancement may become a breach of the physician-patient relationship or the physician's social contract.
Enhancement will also appeal to the physician's self-interest. A willing and paying clientele is certain to develop. Patients will be more eager to pay for the enhancement of the lifestyles they desire than for treatment of diseases they did not want in the first place. Physicians can say they are doing "good" for their patients even while doing well for themselves.
The possibility and probability of a serious conflict of interests on the part of the physician cannot be ignored. Money can easily induce the physician to provide enhancement of dubious merit or marginal efficacy. More specific, for example, is the conflict that involves the team physician who is expected to do his part to produce a winning team. Enhancements of athletic performance are in worldwide use. Their deleterious side effects are well known. Who does the physician serve — the good of the patient, the success of the team that pays his salary, or his own infatuation with athletic success?
Fundamental questions about how enhancement affects our concepts of the purposes of human life and the nature of human happiness will be buried by more immediate demands for happiness, fulfillment, and mental tranquility [3]. The modern and post-modern emphasis will be on effective regulatory measures, better techniques, and competent practitioners — not ethical restraint. Restraint or prohibition beyond prevention of abuses and harmful side effects is highly unlikely. Those who restrict freedom of choice will be seen as a danger to the realization of a higher quality of life for all. Any restriction will be interpreted as a violation of the physician's obligation to respect patient autonomy.
Many of us will take these to be specious arguments, which, if accepted, would make medicine the handmaiden of biotechnology and erode its traditional role in treating the sick. Counterarguments will be difficult given the powerful vectors of change in our cultural mores. Hopes for an earthly paradise are seemingly within reach for many people who no longer believe in an after-life. For them, extracting the maximum from personal enhancement is a seductive substitute.
 |
|
|
Edmund D. Pellegrino, M.D., is Professor Emeritus of Medicine and Medical Ethics at the Center for Clinical Medical Ethics at Georgetown University Medical Center. He was the John Carroll Professor of Medicine and Medical Ethics and the former director of the Kennedy Institute of Ethics, the Center for the Advanced Study of Ethics at Georgetown University, and the Center for Clinical Bioethics. Dr. Pellegrino is a Senior Fellow of The Center for Bioethics and Human Dignity.
References
1 Parens, E. 1998. "Is better always good?" In: E., Parens (Ed.), Enhancing human traits: Ethical and social implications (pp. 1-28). Washington, DC: Georgetown University Press; Jeungst, E. 1998. "What does enhancement mean?" In: E., Parens (Ed.), Enhancing human traits: Ethical and social implications (pp. 29-69). Washington, DC: Georgetown University Press.
2 Fowler, H. J. 1965. A dictionary of English usage. 2nd Edition. Revised by Sir Ernest Gowers. New York, NY: Oxford University Press.
3 Krammer, P. 1993. Listening to Prozac. New York: Viking.
On the net:
The Center for Bioethics and Human Dignity
www.cbhd.org
www.cbhd.org/resources/biotech/pellegrino_2004-11-30.htm
|
Popular tags:
research and development ethics damage human embryos mental illnesses human beings relief physicians implications medicines |
|||||
|
|
Comments
article ID: 450042 http://www.biotechcrossing.com/article/450042/Biotechnology-Human-Enhancement-and-the-Ends-of-Medicine/ article title: Biotechnology, Human Enhancement, and the Ends of Medicine
|
||
| Comment not found for this article. |  |
|
 add comments
|
|
|
|
Related articles
|
|
Facebook comments: |
| You're Brilliant, Extremely Logical, Rational and Have High Standards for Yourself |
|
Top jobs are scattered on the websites of tens of thousands of companies, organizations and other job boards. This presents a difficult theoretical challenge that we help you overcome: By researching, structuring and logically ordering this tremendous variety of jobs in one place, we give you the ability to be resourceful and independently analyze your career options an efficient way. Other job sites are inefficient because they only show you jobs that employers are paying to post there. We actually go out and research jobs and do not accept any money from advertisers for job postings so that we can provide you with unbiased research about every job opening. We give you the resources to analyze your career options in a reserved, calm, independent and analytical manner. |
|
Tell us where to send your access instructions:
|
|
total jobs on EmploymentCrossing |
| 3,498,334 |
|
|
new jobs this week on EmploymentCrossing |
| 627,000 |
|
|
Job Type Count on BiotechCrossing |
|
Clinical Jobs 2,035 Biotech Associate Jobs 891 Biotech Manager Jobs 422 Biotech Director Jobs 353 Biotech Coordinator Jobs 291 Biotech Specialist Jobs 236 Biotech Assistant Jobs 160 |
| Get your risk FREE trial |
 |
| jobs near you | |
|
International jobs Work at home jobs |
UK jobs Canada jobs |
|
New search feature using US map. click here
Looking for a new biotech job in your city? click here |
|
| most recent articles |
| Relationships, Inefficiency, and Your Career |
|
One of the greatest obstacles for efficient businesses is the influence of relationships. In fact, relationships are sometimes so strong that they can ultimately end up crippling a business. |
|
biotech industry news:
|
|
recent articles:
|
|
|
| top 5 job searches |
|
| today's featured job |
|
Physical Therapist / Physical Therapy Assist.
United States-FL-Boca Raton Currently looking for a Lic. Physical Therapist / Physical Therapy Assistant for a small but growing Physical Therapy Clinic. Part Time / PRN with ... 
|
|
|
|
|||||||||
|
||||
|
Free Report
The Five "Big Dirty Secrets" of Job Sites Just enter your email to get the Report |
|
 |
|
|
||||
 |
